Literature DB >> 33287602

Indoor-related microbe damage induces complement system activation in building users.

Janne Atosuo1,2, Outi Karhuvaara1,2, Eetu Suominen1,2, Liisa Vilén2, Jari Nuutila1, Tuula Putus2.   

Abstract

In this comparative study, serum complement system antimicrobial activity was measured from 159 serum samples, taken from individuals from microbe-damaged (70 samples) and from reference buildings (89 samples). Antimicrobial activity was assessed using a probe-based bacterial Escherichia coli-lux bioluminescence system and comparison was made at a group level between the experimental and reference group. The complement activity was higher in users of microbe-damaged buildings compared with the reference group and the significant (P < 0.001) increase in activity was found in the classical reaction pathway. This study strengthens our notion that exposure to indoor-related microbe damage increases the risk for systemic subclinical inflammation and creates a health risk for building users.

Entities:  

Keywords:  Complement system; classical pathway; exposure; indoor mold and bacteria; inflammation

Mesh:

Substances:

Year:  2020        PMID: 33287602      PMCID: PMC7780350          DOI: 10.1177/1753425920966641

Source DB:  PubMed          Journal:  Innate Immun        ISSN: 1753-4259            Impact factor:   2.680


  26 in total

Review 1.  Role of complement in innate and autoimmunity.

Authors:  Marc A J Seelen; Anja Roos; Mohamed R Daha
Journal:  J Nephrol       Date:  2005 Nov-Dec       Impact factor: 3.902

2.  3D structure of the C3bB complex provides insights into the activation and regulation of the complement alternative pathway convertase.

Authors:  Eva Torreira; Agustín Tortajada; Tamara Montes; Santiago Rodríguez de Córdoba; Oscar Llorca
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-09       Impact factor: 11.205

Review 3.  Complement: coming full circle.

Authors:  Gaëlle Le Friec; Gaëlle Le Friec; Claudia Kemper
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2009-10-29       Impact factor: 4.291

Review 4.  Molecules Great and Small: The Complement System.

Authors:  Douglas R Mathern; Peter S Heeger
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-07       Impact factor: 8.237

5.  Activation of the lectin pathway in murine lupus nephritis.

Authors:  Leendert A Trouw; Marc A Seelen; Jacques M G J Duijs; Sven Wagner; Michael Loos; Ingeborg M Bajema; Cees van Kooten; Anja Roos; Mohamed R Daha
Journal:  Mol Immunol       Date:  2005-04       Impact factor: 4.407

6.  Indoor exposure to Streptomyces albus and Aspergillus versicolor elevates the levels of spore-specific IgG, IgG1 and IgG3 serum antibodies in building users - A new ELISA-based assay for exposure assessment.

Authors:  Janne Atosuo; Outi Karhuvaara; Eetu Suominen; Liisa Vilén; Jari Nuutila; Tuula Putus
Journal:  Sci Total Environ       Date:  2019-09-06       Impact factor: 7.963

Review 7.  The complement system as a potential therapeutic target in rheumatic disease.

Authors:  Leendert A Trouw; Matthew C Pickering; Anna M Blom
Journal:  Nat Rev Rheumatol       Date:  2017-08-10       Impact factor: 20.543

8.  Impact of cyanogen iodide in killing of Escherichia coli by the lactoperoxidase-hydrogen peroxide-(pseudo)halide system.

Authors:  D Schlorke; J Atosuo; J Flemmig; E-M Lilius; J Arnhold
Journal:  Free Radic Res       Date:  2016-10-12

9.  Escherichia coli K-12 (pEGFPluxABCDEamp): a tool for analysis of bacterial killing by antibacterial agents and human complement activities on a real-time basis.

Authors:  Janne Atosuo; Janne Lehtinen; Libor Vojtek; Esa-Matti Lilius
Journal:  Luminescence       Date:  2012-11-06       Impact factor: 2.464

10.  Resistance to oxidative damage but not immunosuppression by organic tin compounds in natural populations of Daubenton's bats (Myotis daubentonii).

Authors:  T M Lilley; L Ruokolainen; A Meierjohann; M Kanerva; J Stauffer; V N Laine; J Atosuo; E-M Lilius; M Nikinmaa
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2013-01-28       Impact factor: 3.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.